APOA4 Antikörper (AA 21-396)
Kurzübersicht für APOA4 Antikörper (AA 21-396) (ABIN968959)
Target
Alle APOA4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 21-396
-
Verwendungszweck
- APOA4 Antibody
-
Aufreinigung
- Ascitic fluid
-
Immunogen
- Purified recombinant fragment of APOA4 (aa21-396) expressed in E. Coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA: 1/10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 388, Issue 1-2, pp. 78-83, (2007) (PubMed).
: "E-cadherin-dependent transcriptional control of apolipoprotein A-IV gene expression in intestinal epithelial cells: a role for the hepatic nuclear factor 4." in: The Journal of biological chemistry, Vol. 281, Issue 6, pp. 3560-8, (2006) (PubMed).
-
-
- APOA4 (Apolipoprotein A-IV (APOA4))
-
Andere Bezeichnung
- APOA4
-
Hintergrund
- APOA4: apolipoprotein A-IV. Apoliprotein (apo) A-IV gene contains 3 exons separated by two introns. A sequence polymorphism has been identified in the 3'UTR of the third exon. The primary translation product is a 396-residue preprotein which after proteolytic processing is secreted its primary site of synthesis, the intestine, in association with chylomicron particles. Although its precise function is not known, apo A-IV is a potent activator of lecithin-cholesterol acyltransferase in vitro.
-
Molekulargewicht
- 45 kDa
-
Gen-ID
- 337
-
UniProt
- P06727
-
Pathways
- Lipid Metabolism
Target
-